KBW Maintains Outperform on SNV - PT $45

Brady Gailey— Keefe, Bruyette & WoodsSNVVisible Alpha

Received

4/9/2026, 7:10:25 PM

Published

10/15/2024, 12:00:00 AM

Summarized

4/9/2026, 7:10:25 PM

AI Summary

**Rating:** Outperform (Maintained)\n**Price Target:** $45\n**Analyst:** Brady Gailey, KBW\n\nKBW maintained its bullish Outperform rating on Synovus after Q3 earnings beat expectations. At this point, Gailey was still positive on SNV as a standalone entity.

Full Report Content (85 characters)

KBW maintains Outperform on Synovus with $45 price target following Q3 2024 earnings.

Metadata

{
  "action": "maintains",
  "rating": "outperform",
  "price_target": 45
}